Recent Update on Carotid Endarterectomy versus Carotid Artery Stenting

Raywat Noiphithak1, Anusak Liengudom

  • 1Division of Neurosurgery, Department of Surgery, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Insights

Carotid artery stenosis (CS) management involves best medical treatment and revascularization (CEA/CAS). This review compares CEA and CAS efficacy and safety, proposing a new decision-making framework for CS patients.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Carotid artery stenosis (CS) is a primary cause of ischemic stroke.
  • Current management includes best medical treatment and carotid revascularization (CR) via carotid endarterectomy (CEA) or carotid artery stenting (CAS).
  • Both CR methods carry procedural risks, complicating patient selection.

Purpose of the Study:

  • To review and compare current evidence on the efficacy and safety of CEA versus CAS for CS.
  • To analyze data from randomized trials, meta-analyses, and ongoing trials.
  • To propose a novel, comprehensive decision-making strategy for CS management.

Main Methods:

  • Systematic review of existing literature.
  • Comparative analysis of randomized controlled trials and meta-analyses.
  • Inclusion of data from ongoing clinical trials.

Main Results:

  • Evidence regarding the comparative efficacy and safety of CEA and CAS remains controversial.
  • Existing studies and guidelines offer varying recommendations for symptomatic and asymptomatic patients.
  • Ongoing trials are crucial for resolving current therapeutic debates.

Conclusions:

  • A nuanced approach is required for selecting optimal treatment for CS.
  • The proposed decision-making framework aims to integrate current data for improved patient outcomes.
  • Further research and trial data are essential for definitive treatment guidelines.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
425
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472